On March 5, 2026, NexCure, a healthcare company with a mission to deliver CAR-T and other clinically intensive treatments in community-based outpatient settings, launched with a $19 million Series A financing. The financing was led by RA Capital Management, with participation from Cencora Ventures and Oncology Ventures. Wilson Sonsini Goodrich & Rosati advised NexCure on the transaction.

The Wilson Sonsini team that advised NexCure on the transaction includes Jen Fang, Leah Hengemuhle, Alex Stebbins, and Matt Ierardi.

For more information, please see NexCure’s news release.